Europe Archives - Page 51 of 93 - Journal for Clinical Studies

Current Edition

Europe

Nanobiotix: Positive Phase II / III Results for NBTXR3 in Soft Tissue Sarcoma Presented at ESMO

Dr. Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at Institut Curie - Paris, presented first-in-class NBTXR3 positive Phase II/III results during...

25 October 2018 Europe | news | North America | Regional News

Continue Reading →

Europe

Balixafortide combination with eribulin in metastatic breast cancer data presented at ESMO 2018 show consistent positive trend for all efficacy endpoints, including overall survival

Balixafortide combination with eribulin in metastatic breast cancer data presented at ESMO 2018 show consistent positive trend for all efficacy endpoints, including o...

25 October 2018 Europe | news | Regional News

Continue Reading →

Europe

Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec Nanomedicine Drug Candidate in Ovarian Cancer

Maastricht, The Netherlands, October 25, 2018 / B3C newswire / -- Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for th...

25 October 2018 Europe | news | Regional News

Continue Reading →

Europe

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Continued investment at Bridgend site enables capacity expansion for segregated space in support of the Return of investigational drug products used in Clinical studi...

22 October 2018 Europe | news | Regional News

Continue Reading →

Europe

NHS High Throughput Clinical Research Centres Could Bring Substantial Benefits for Patients

New whitepaper details the potential of High Throughput Centres to make U.K. country of choice for clinical research. Maidenhead, United Kingdom, 8 October 2018 – A n...

18 October 2018 Europe | news | Regional News

Continue Reading →

Asia Pacific

Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis

Servier, an independent international pharmaceutical company, and the company Galapagos NV announce the start of a global Phase 2 trial with S201086/GLPG1972 in knee...

Continue Reading →

Europe

Study using DFMO shows positive results for children with high risk neuroblastoma

A paper published September 27 in Scientific Reports shows the positive results of a phase II clinical trial using the oral medication DFMO to prevent relapse in chil...

3 October 2018 Europe | news | Regional News

Continue Reading →

Europe

Human clinical trial of investigational calcification inhibitor generates promising results

Cardiovascular calcification is a major health concern in patients with kidney failure undergoing hemodialysis. A first-time-in-human clinical trial of an investigati...

3 October 2018 Europe | news | Regional News

Continue Reading →

Asia Pacific

Blockchain to Combat Type 2 Diabetes Epidemic in India

Genomics pioneer Shivom hopes to transform diagnosis and treatment of a disease that’s pervasive in the country. London, UK - 25 September 2018: A pioneering diabetes...

3 October 2018 Asia Pacific | Europe | news | Regional News

Continue Reading →

Europe

Catalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies

GB Sciences and Catalent tackle the first-ever formulations of APIs containing up to nine cannabinoids and terpenoids for the treatment of Parkinson’s disease. SWINDO...

3 October 2018 Europe | news | North America | Regional News

Continue Reading →